Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting.

Journal Information

Full Title: Mol Immunol

Abbreviation: Mol Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that they have no conflict of interest."

Evidence found in paper:

"This work was supported by the CCHD PhD program of the Austrian Science Fund FWF, project # APW01205FW (JS, EJJ), APP23398FW (MW, EJJ), APP22441FW (DM), by RotePfote – Cancer research for companion animals – grants, project # FA644A0106, FA648A1301 and a von Fircks Fund scholarship for doctoral students (MW)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025